Brian Steingo, MD
MEDICAL SPECIALTY:
Neurology
EDUCATION:
University of the Witwatersrand, Johannesburg, South Africa
Bachelor of Science, Microbiology, Biochemistry, 1968
University of the Witwatersrand Johannesburg, South Africa
Doctor of Medicine, 1971
POST-DOCTORAL TRAINING:
Johannesburg General Hospital, Johannesburg, South Africa
Internship in Medicine, 1972
Johannesburg Hospitals Complex, Johannesburg, South Africa
Department of Neurology, January 1973 – June 1973
Department of Pediatrics, July 1971 – December 1973
Department of Internal Medicine, 1974 – 1975
Medical Resident Teaching Program Coordinator, 1974 – 1976
Medical University of South Carolina, Charleston, SC
Department of Neurology, April 1977 – June 1978
Baylor College of Medicine, Houston, TX
Department of Neurology, July 1978 – June 1980
Chief Resident, July 1978 – July 1979
University of the Witwatersrand, Johannesburg, South Africa
Bachelor of Science, Microbiology, Biochemistry, 1968
BOARD CERTIFICATION:
American Board of Psychiatry & Neurology
Diplomate in Neurology, May 1983
LICENSURE:
Florida ME 36908
HOSPITAL AFFILIATION:
Imperial Point Medical Center
6401 North Federal Highway
Fort Lauderdale, FL 33308
GCP TRAINING:
CITI TRAINING – 3/12/2014
PROFESSIONAL ORGANIZATIONS:
American Academy of Neurology
Broward County Medical Association
Florida Medical Association
EXPERIENCE:
Infinity Clinical Research, LLC
3537 North Pine Island Road
Sunrise, FL 33351
Principal Investigator, 01/15 – Present
Sunrise Medical Group
3540 North Pine Island Road
Sunrise, FL 33351
Clinical Neurologist, 09/14 – Present
Infinity Clinical Research, LLC
(Formerly: Multiple Sclerosis Research Associates, PLLC)
(dba Neurological Associates)
572 East McNab Road, Suite 202
Pompano Beach, FL 33060
Principal Investigator, 01/12 – 12/14
Sunrise Medical Group, Inc.
572 East McNab Road, Suite 200
Pompano Beach, FL 33060
Clinical Neurologist, 12/04 – 12/14
MS Center of Fort Lauderdale
(formerly – MS Clinic at North Ridge NeuroScience Center)
572 East McNab Road, Suite 202
Pompano Beach, FL 33060
Director, 1998 – Present
Steingo & Kishner, MD, PA
North Ridge NeuroScience Center
5757 North Dixie Highway
Fort Lauderdale, AL 33334
Clinical Neurologist, 1998 – 12/2004
Steingo & Kishner, MD, PA
5333 North Dixie Highway
Fort Lauderdale, FL 33334
Clinical Neurologist, 1984 – 1997
VOLUNTEER ACTIVITIES:
National MS Society
National Advisory Board Member, 2004-Present
National MS Society, South Florida Chapter
Professional Advisory Committee Member, 1989 – 1997
Chairman, 1997 – Present
Board of Trustees, Member, 1995 – Present
Service & Education Committee Chairman, 1993 – 1997
Attending physician for neurology residents, Nova Southeastern University, Fort Lauderdale, FL – Current
PUBLICATIONS:
Calkwood, J., Cree, B., Crayton, H., Kantor, D., Steingo, B., Barbato,L., Hashmonay, R., Agashivala, N., McCague, K., Tenenbaum, N. and Edwards, K. (2014) Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient and physician reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial. BMC Neurology. 14:220
Cree, B. A., Steingo, B. (2012) Emerging challenges on the therapeutic landscape of multiple sclerosis: The managed care physician’s perspective and medical director’s perspective. Journal of Managed Care Medicine. Vol.15, No.4
Ortega, M., Usmani N., Parra-Herran, C., Adams, D., Steingo, B., Rammohan, K. (2012) CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma. Neurology 79:715-716
Saffer, D. S., Steingo, B., Bill P. L. (1977). The diagnosis and significance of isolated third nerve palsy in the African. Trop Geogr Med. Jun; 29(2):155-8
Saffer, D. S., Nathan D.C., Kahle P. A. , Steingo B. (1974). Huntington’s disease in a Coloured family. S Afr Med J. Nov 30; 48(58):2399–2402
RECENT PRESENTATIONS:The Multiple Sclerosis Association of America, (2009-2014):
“Charting Your Multiple Sclerosis Treatment Course: An Update on MS Therapies and Research.”
“How to S.E.A.R.C.H. for the Right MS Therapy for You!”
“MS in the Twenty-First Century- Moving Forward.”
NAMCP, Las Vegas, Nevada (November 2011):
“New and Evolving Therapies in Multiple Sclerosis: The Managed Care Perspective.”
Symposiums for Managed Care Physicians: Pasadena, New York City, San Francisco, Chicago, Philadelphia, Boston (2012 and 2013): “Multiple Sclerosis in the Managed Care Setting.”
Prime CME Faculty: Multiple Presentations
CME Panel Philadelphia, May 2014. (Sponsored by CMEducation)
Speaker and consultant for multiple pharma companies including Acorda, Biogen, Genzyme, Pfizer, Questcor, Serono and TEVA.
RESEARCH EXPERIENCE: Provided upon request
